Savine Therapeutics' Other Investors

Savine Therapeutics raised a round of funding on , . Investors include ANU Connect.

The focus of Savine Therapeutics is to develop and commercialise vaccines for prevention and treatment of diseases using it's Scrambled Antigen Vaccine (SAVINE) technology.  The technology was invent…

Articles about Savine Therapeutics' Other Investors: